| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |